Literature DB >> 22217391

Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models.

Cinzia Borgogna1, Elisa Zavattaro, Marco De Andrea, Heather M Griffin, Valentina Dell'Oste, Barbara Azzimonti, Manuela M Landini, Woei Ling Peh, Herbert Pfister, John Doorbar, Santo Landolfo, Marisa Gariglio.   

Abstract

This study provides a first characterisation of β-HPV life-cycle events in tumours abscised from EV patients (the human model of β-HPV-induced skin cancer), and shows how changes in E4 expression patterns relate to disease severity. β-HPV life-cycle has also been reconstructed in organotypic raft cultures created using EV-derived keratinocytes. In EV lesions and raft cultures, abundant cytoplasmic E4 expression was detectable in differentiating cells along with viral genome amplification as reported for other HPV types. E4 expression was also seen in PCNA-positive basal cells in some EV skin cancers as well as in tumours from HPV8CER (Complete Early Region) transgenic mice. In these lesions, E4 staining extended throughout the full thickness of the epithelium and was apparent in the markedly atypical cells. The loss of such staining at the tumour border suggests a distinct type of E4 dysregulation that may be exploited as a marker of viral expression during β-HPV-associated skin cancer progression.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22217391     DOI: 10.1016/j.virol.2011.11.029

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

Review 1.  Tissue-engineered skin substitutes: an overview.

Authors:  Enrico Catalano; Andrea Cochis; Elena Varoni; Lia Rimondini; Barbara Azzimonti
Journal:  J Artif Organs       Date:  2013-10-05       Impact factor: 1.731

Review 2.  Model systems to study the life cycle of human papillomaviruses and HPV-associated cancers.

Authors:  Louise T Chow
Journal:  Virol Sin       Date:  2015-04-23       Impact factor: 4.327

Review 3.  HPV vaccination for prevention of skin cancer.

Authors:  Sabrina E Vinzón; Frank Rösl
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Human Papillomavirus (HPV) Entry Inhibitors.

Authors:  Yun Zhu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation.

Authors:  Yunji Zheng; Xue Li; Yisheng Jiao; Chengjun Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-27       Impact factor: 6.073

6.  Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study.

Authors:  Shohreh F Farzan; Tim Waterboer; Jiang Gui; Heather H Nelson; Zhongze Li; Kristina M Michael; Ann E Perry; Steven K Spencer; Eugene Demidenko; Adele C Green; Michael Pawlita; Margaret R Karagas
Journal:  Int J Cancer       Date:  2013-04-22       Impact factor: 7.396

7.  Expression of betapapillomavirus oncogenes increases the number of keratinocytes with stem cell-like properties.

Authors:  Martin Hufbauer; Adrian Biddle; Cinzia Borgogna; Marisa Gariglio; John Doorbar; Alan Storey; Herbert Pfister; Ian Mackenzie; Baki Akgül
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

Review 8.  Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches.

Authors:  Zoe Apalla; Dorothée Nashan; Richard B Weller; Xavier Castellsagué
Journal:  Dermatol Ther (Heidelb)       Date:  2017-02-01

9.  Eyebrow hairs from actinic keratosis patients harbor the highest number of cutaneous human papillomaviruses.

Authors:  Ines Schneider; Mandy D Lehmann; Vlada Kogosov; Eggert Stockfleth; Ingo Nindl
Journal:  BMC Infect Dis       Date:  2013-04-24       Impact factor: 3.090

10.  Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration.

Authors:  Tanya Sperling; Monika Ołdak; Barbara Walch-Rückheim; Claudia Wickenhauser; John Doorbar; Herbert Pfister; Magdalena Malejczyk; Sławomir Majewski; Andrew C Keates; Sigrun Smola
Journal:  PLoS Pathog       Date:  2012-07-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.